Natural antisense and non-coding RNA transcripts as drug targets
US9803195B2 · kind B2 · utility
1Cited by
238References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 31, 2012 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Nov 28, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2330/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Small interfering RNA (siRNA) knock down antisense transcripts, and regulate the expression of their sense partners. This regulation can either be discordant (antisense knockdown results in sense transcript elevation) or concordant (antisense knockdown results in concomitant sense transcript reduction).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.